Related Experiment Video
Updated: May 6, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Endoscopic injection sclerosis: effective treatment for bleeding peptic ulcer
1Gastroenterology Unit, Western General Hospital, Edinburgh.
Endoscopic injection sclerotherapy significantly reduced rebleeding rates in patients with severe peptic ulcer hemorrhage. This effective treatment offers a safer alternative to conservative management for high-risk individuals.
Area of Science:
- Gastroenterology
- Endoscopic interventions
- Hemorrhage management
Background:
- Peptic ulcer disease is a common cause of upper gastrointestinal bleeding.
- Severe hemorrhage necessitates effective and timely intervention.
- Identifying high-risk patients is crucial for treatment selection.
Purpose of the Study:
- To evaluate the efficacy of endoscopic injection sclerotherapy versus conservative treatment for severe peptic ulcer hemorrhage.
- To compare rebleeding rates and need for surgery between the two treatment groups.
Main Methods:
- Randomized controlled trial involving 109 high-risk patients with severe peptic ulcer hemorrhage.
- Intervention group received endoscopic injection sclerotherapy (adrenaline and ethanolamine).
- Control group received conservative management.
Main Results:
- Significantly lower rebleeding rate in the endoscopic injection sclerotherapy group (12.5% vs. 47%, p < 0.001).
- Successful rebleeding treatment with sclerotherapy or surgery.
- Tendency towards lower operation rates and transfusion requirements in the treated group, though not statistically significant.
Conclusions:
- Endoscopic injection sclerotherapy is effective in preventing rebleeding in patients with severe peptic ulcer hemorrhage.
- This endoscopic approach offers a valuable therapeutic option for high-risk patients.
- Further research may explore optimizing surgical intervention rates and transfusion needs.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

